View in EDS

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.

Saved in:
Bibliographic Details
Title: A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.
Authors: Clark AS; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Zhao F; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Klein P; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York., Montero AJ; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio., Falkson C; University of Rochester, Rochester, New York., Krill-Jackson E; University of Miami, Miami, Florida., Rowland K; Carle Cancer Center, Urbana, Illinois., Sardesai S; Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Incorvati J; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Dillon P; University of Virginia, Charlottesville, Virginia., Wolff AC; Johns Hopkins University, Baltimore, Maryland., Trauger R; Oncolytics Biotech, San Diego, California., Heineman TC; Oncolytics Biotech, San Diego, California., Coffey MC; Oncolytics Biotech, Calgary, Alberta., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jul 01; Vol. 31 (13), pp. 2655-2662.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40300087
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Clark+AS%22">Clark AS</searchLink>; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Zhao+F%22">Zhao F</searchLink>; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Klein+P%22">Klein P</searchLink>; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York.<br /><searchLink fieldCode="AU" term="%22Montero+AJ%22">Montero AJ</searchLink>; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Falkson+C%22">Falkson C</searchLink>; University of Rochester, Rochester, New York.<br /><searchLink fieldCode="AU" term="%22Krill-Jackson+E%22">Krill-Jackson E</searchLink>; University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Rowland+K%22">Rowland K</searchLink>; Carle Cancer Center, Urbana, Illinois.<br /><searchLink fieldCode="AU" term="%22Sardesai+S%22">Sardesai S</searchLink>; Ohio State University Comprehensive Cancer Center, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Incorvati+J%22">Incorvati J</searchLink>; Fox Chase Cancer Center, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Dillon+P%22">Dillon P</searchLink>; University of Virginia, Charlottesville, Virginia.<br /><searchLink fieldCode="AU" term="%22Wolff+AC%22">Wolff AC</searchLink>; Johns Hopkins University, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Trauger+R%22">Trauger R</searchLink>; Oncolytics Biotech, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Heineman+TC%22">Heineman TC</searchLink>; Oncolytics Biotech, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Coffey+MC%22">Coffey MC</searchLink>; Oncolytics Biotech, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Miller+KD%22">Miller KD</searchLink>; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Jul 01; Vol. 31 (13), pp. 2655-2662.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40300087
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-24-2701
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2655
    Titles:
      – TitleFull: A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Clark AS
      – PersonEntity:
          Name:
            NameFull: Zhao F
      – PersonEntity:
          Name:
            NameFull: Klein P
      – PersonEntity:
          Name:
            NameFull: Montero AJ
      – PersonEntity:
          Name:
            NameFull: Falkson C
      – PersonEntity:
          Name:
            NameFull: Krill-Jackson E
      – PersonEntity:
          Name:
            NameFull: Rowland K
      – PersonEntity:
          Name:
            NameFull: Sardesai S
      – PersonEntity:
          Name:
            NameFull: Incorvati J
      – PersonEntity:
          Name:
            NameFull: Dillon P
      – PersonEntity:
          Name:
            NameFull: Wolff AC
      – PersonEntity:
          Name:
            NameFull: Trauger R
      – PersonEntity:
          Name:
            NameFull: Heineman TC
      – PersonEntity:
          Name:
            NameFull: Coffey MC
      – PersonEntity:
          Name:
            NameFull: Miller KD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1